The thymine DNA glycosylase MBD4 represses transcription and is associated with methylated p16INK4a and hMLH1 genes

Molecular and Cellular Biology

Volumn 25, Issue 11, 2005, Pages 4388-4396

  Kondo, Emiko ^a   Gu, Zhaodi ^a   Horii, Akira ^a   Fukushige, Shinichi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; PROTEIN MBD4; THYMINE DNA GLYCOSYLASE; TRANSCRIPTION FACTOR SIN3A; UNCLASSIFIED DRUG;

ARTICLE; CANCER; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; EMBRYO; ENZYME BINDING; ENZYME MECHANISM; GENE; GENE SILENCING; GENETIC EPIGENESIS; HMLH1 GENE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METHYLATION; P16INK4A GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

CARRIER PROTEINS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; ENDODEOXYRIBONUCLEASES; EPIGENESIS, GENETIC; GENE SILENCING; HISTONE DEACETYLASES; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN INTERACTION MAPPING; REPRESSOR PROTEINS; THYMINE DNA GLYCOSYLASE; TRANSCRIPTION, GENETIC;

EID: 18944404300     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.11.4388-4396.2005     Document Type: Article

References (37)

1. Alland, L., R. Muhle, H. Hou, Jr., J. Potes, L. Chin, N. Schreiber-Agus, and R. A. DePinho. 1997. Role for N-CoR and historic deacetylase in Sin3-mediated transcriptional répression. Nature 387:49-55.
2. Bachman, K. E., B. H. Park, I. Rhee, H. Rajagopalan, J. G. Herman, S. B. Baylin, K. W. Kinzler, and B. Vogelstein. 2003. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell. 3:89-95.
3. Bader, S., M. Walker, B. Hendrich, A. Bird, C. Bird, M. Hooper, and A. Wyllie. 1999. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 18:8044-8047.
4. Ballestar, E., M. F. Paz, L. Valle, S. Wei, M. F. Fraga, J. Espada, J. C. Cigudosa, T. H.-M. Huang, and M. Esteller. 2003. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22:6335-6345.
5. Ballestar, E., and A. P. Wolffe. 2001. Methyl-CpG-hinding proteins. Targeting specific gene repression. Eur. J. Biochem. 268:1-6.
6. Bellacosa, A. L. Cicchillitti, F. Schepis, A. Riccio, A. T. Yeung, Y. Matsumoto, E. A. Golemis, M. Genuardi, and, G., Neri. 1999. MED1, a novel human methyl-CpG-hinding endonuclcase, interacts with DNA mismatch repair protein MLH1. Proc. Natl. Acad. Sci. USA 96:3969-3974.
7. Choi, Y., M. Gehring, L. Johnson, M. Hannon, J. J. Harada, R. B. Goldberg, S. E. Jacobsen, and R. L. Fischer. 2002. DEMETER, a DNA glycosylase domain protein, is required for endosperm gene imprinting and seed viability in Arabidopsis. Cell 110:33-42.
8. Cortellino, S., D. Turner, V. Masciullo, F. Schepis, D. Albino, R. Daniel, A. M. Skalka, N. J. Meropol, C. Alberti, L. Larue, A. Bellacosa. 2003. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc. Natl. Acad. Sci. USA 100:15071-15076.
9. Fukushige, S., and, B., Sauer. 1992. Genomic targeting with a positive-selection to integration vector allows highly reproducible gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 89:7905-7909.
10. Heinzel, T., R. M. Lavinsky, T.-M. Mullen, M. Söderström, C. D. Laherty, J. Torchia, W.-M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
11. Hendrich, B., and, A. Bird. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18: 6538-6547.
12. Hendrich, B., U. Hardeland, H.-H. Ng, J. Jiricny, and A. Bird. 1999. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401:301-304.
13. Jaenisch, R., and A. Bird. 2003. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33:245-254.
14. Kondo, E., T. Furukawa, K. Yoshinaga, H. Kijima, S. Semba, T. Yatsuoka, T. Yokoyama, S. Fukushige, and A. Horii. 2000. Not hMSH2 but HMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability. Int. J. Oncol. 17: 535-541.
15. Kondo, E., A. Horii, and S. Fukushige. 2001. The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2. Nucleic Acids Res. 29:1695-1702.
16. Kondo, Y., L. Shen, P. S. Yan, T. H.-M. Huang, and J.-P. J. Issa. 2004. Chromatin immunoprecipitation microassays for identification of genes silenced by histone H3 lysine 9 methylation. Proc. Natl. Acad. Sci. USA 101: 7398-7403.
17. Likhite, V. A., E. I. Cass, S. D. Anderson, J. R. Yates, and A. M. Nardulli. 2004. Interaction of estrogen receptor α with 3-methyladenine DNA glycosylase modulates transcription and DNA repair. J. Biol. Chem. 279:16875-16882.
18. Magdinier, F., and A. P. Wolffe. 2001. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. USA 98:4990-4995.
19. Meehan, R. R., J. D. Lewis, S. McKay, E. L. Kleiner, and A. P. Bird. 1989. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58:499-507.
20. Millar, C. B., J. Guy, O. J. Sansom, J. Selfridge, E. MacDougall, B. Hendrich, P. D. Keightley, S. M. Bishop, A. R. Clarke, and, A. Bird. 2002. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297:403-405.
21. Missero, C., M. T. Pirro, S. Simeone, M. Pischetola, and R. Di Lauro. 2001. The DNA glycosylase T:G mismatch-specific thymine DNA glycosylase represses thyroid transcription factor-1-activated transcription. J. Biol. Chem. 276:33569-33575.
22. Nan, X., H.-H. Ng, C. A. Johnson, C. D. Laherty, B. M. Turner, R. N. Eisenman, and A. Bird. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389.
23. Ng, H.-H., Y. Zhang, B. Hendrich, C. A. Johnson, B. M. Turner, H. Erdjument-Bromage, P. Tempst, D. Reinberg, and, A. Bird. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23:58-61.
24. Paz, M. F., M. F. Fraga, S. Avila, M. Guo, M. Pollan, J. G. Herman, and M. Esteller. 2003. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 63:1114-1121.
25. Petronzelli, F., A. Riccio, G. D. Markham, S. H. Seeholzer, J. Stoerker, M. Genuardi, A. T. Yeung, Y. Matsumoto, and A. Bellacosa. 2000. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. J. Biol. Chem. 275:32422-32429.
26. Riccio, A., L. A. Aaltonen, A. K. Godwin, A. Loukola, A. Percesepe, R. Salovaara, V. Masciullo, M. Genuardi, M. Paravatou-Petsotas, D. E. Bassi, R. A. Ruggeri, A. J. P. Klein-Szanto, J. R. Testa, G. Neri, and A. Bellacosa. 1999. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat. Genet. 23:266-268.
27. Saito, M., and F. Ishikawa. 2002. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J. Biol. Chem. 277:35434-35439.
28. Sansom, O. J., J. Zabkiewicz, S. M. Bishop, j. Guy, A. Bird, and A. R. Clarke. 2003. MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine. Oncogene 22:7130-7136.
29. Sansom, O. J., S. M. Bishop, A. Bird, and A. R. Clarke. 2004. MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMR. Oncogene 23:5693-5696.
30. Trojan, J., S. Zeuzem, A. Randolph, C. Hemmerle, A. Brieger, J. Raedle, G. Plotz, J. Jiricny, and G. Marra. 2002. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology. 122:211-219.
31. Um, S., M. Harbers, A. Benecke, B. Pierrat, R. Losson, and P. Chambon. 1998. Retinoic acid receptors interact physically and functionally with the T:G mismatch-specific thymine-DNA glycosylase. J. Biol. Chem. 273:20728-20736.
32. Veigl, M. L., L. Kasturi, J. Olechnowicz, A. Ma, J. D. Lutterbaugh, S. Periyasamy, G.-M. Li, J. Drummond, P. L. Modrich, W. D. Sedwick, and S. D. Markowitz. 1998. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MS1 cancers. Proc. Natl. Acad. Sci. USA 95:8698-8702.
33. Watanabe, S., T. Ichimura, N. Fujita, S. Tsuruzoe, I. Ohki, M. Shirakawa, M. Kawasuji, and M. Nakao. 2003. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc. Natl. Acad. Sci. USA 100:12859-12864.
34. Wong, E., K. Yang, M. Kuraguchi, U. Werling, E. Avdievich, K. Fan, M. Fazzari, B. Jin, A. M. C. Brown, M. Lipkin, and W. Edelmann. 2002. Mbd4 inactivation increases C→T transition mutations and promotes gastrointestinal tumor formation. Proc. Natl. Acad. Sci. USA 99:14937-14942.
35. Yamakawa, K., S. Mitchell, R. Hubert, X. N. Chen, S. Colbern, Y. K. Huo, C. Gadomski, U. J. Kim, and J. R. Korenberg. 1995. Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum. Mol. Genet. 4:709-716.
36. Yatsuoka, T., T. Furukawa, M. Sunamura, S. Matsuno, and A. Horii. 2004. TU12B1-TY, a novel gene in the region at 12q22-q23.1 frequently deleted in pancreatic cancer, shows reduced expression in pancreatic cancer cells. Oncol. Rep. 12:1263-1268.
37. Zhu, B., Y. Zheng, H. Angliker, S. Schwarz, S. Thiry, M. Siegmann, and J.-P. Jost. 2000. 5-methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence. Nucleic Acids Res. 28:4157-4165.